Pharmaceutical formulation for histone deacetylase inhibitors
US9255066B2 · kind B2 · utility
0Cited by
8References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 13, 2011 |
| Grant date | Feb 9, 2016 |
| Priority date | — |
| Expiry date | Oct 13, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C259/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition, comprising a therapeutically effective amount of an active pharmaceutical ingredient (API) compound represented by the following structural formula at least one acidifying agent; and a vehicle base comprising at least one pharmaceutically acceptable non-aqueous solvent. Values and preferred values of the variables in structural formula (I) are defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.